JNJ earnings: next report 2026-10-13, real EPS beat/miss history, analyst consensus Buy, P/E 29.55. Updated 2026-07-23.
Johnson & Johnson (JNJ) Research Hub
Johnson & Johnson (JNJ) trades on NYSE, US in the Healthcare (Drug Manufacturers - General) sector. As of 2026-09-11, shares last closed at 265.58 USD (-0.56%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 29.55, market cap 614.32B. This hub links to the full technical, earnings and options research available for JNJ.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Drug Manufacturers - General) |
|---|---|
| Exchange | NYSE, US |
| Last close | 265.58 USD (-0.56%) |
| 52-week range | 227.5 USD – 278.89 USD |
| Trend regime | Range |
| 14-day RSI | 56.5 (Bullish) |
| Trailing P/E | 29.55 |
| Market cap | 614.32B |
| Dividend yield | 2.05% |
| Next earnings | 2026-10-13 |
Available research for JNJ
Covered Call on JNJ: how it works, illustrative setup around the real 265.58 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on JNJ: how it works, illustrative setup around the real 265.58 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on JNJ: how it works, illustrative setup around the real 265.58 USD price, max profit/loss, breakeven and when to use it. Educational.
JNJ technical analysis: range, last 265.58 USD, RSI 56.5, 52w range 227.5 USD–278.89 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is JNJ in?
Johnson & Johnson (JNJ) is classified under Healthcare (Drug Manufacturers - General), listed on NYSE, US.
Is JNJ in an uptrend or downtrend?
As of 2026-09-11, JNJ is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is JNJ's trailing P/E ratio?
JNJ's trailing P/E is 29.55, with a market cap of 614.32B. See the earnings research page for full valuation detail.
When does JNJ next report earnings?
JNJ is next scheduled to report earnings on 2026-10-13, with a consensus EPS estimate of 3.04 USD.